THERAVANCE BIOPHARMA (TBPH) insider trading activity (SEC Form 4). Over the trailing 90 days, TBPH insiders filed 0 purchases totalling $0 and 1 sales totalling $227K — net SELLING of $227K. Most recent filing: Sep 17, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S Sale | — | $17.03 | $227K | filing |
| Jul 8, 2026 | Samaha Eli | 10% | S Sale | — | $17.14 | $119K | filing |
| Jul 1, 2026 | Samaha Eli | 10% | S Sale | — | $17.20 | $5.8M | filing |
| Jun 17, 2026 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S Sale | — | $16.39 | $218K | filing |